Ooma Inc: Form 10-Q for the period ended Oct 31, 2020
Filed with the SEC on Dec 4, 2020 and accepted by EDGAR at Dec 4, 2020, 16:30 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2020-10-31. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2020-08-01 to 2020-10-31 | $43.0m | us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax |
| Revenue | 9 months2020-02-01 to 2020-10-31 | $124.7m | us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax |
| Cost of revenue | 3 months2020-08-01 to 2020-10-31 | $16.3m | us-gaap:CostOfGoodsAndServicesSold |
| Cost of revenue | 9 months2020-02-01 to 2020-10-31 | $47.3m | us-gaap:CostOfGoodsAndServicesSold |
| Gross profit | 3 months2020-08-01 to 2020-10-31 | $26.7m | us-gaap:GrossProfit |
| Gross profit | 9 months2020-02-01 to 2020-10-31 | $77.4m | us-gaap:GrossProfit |
| Research and development | 3 months2020-08-01 to 2020-10-31 | $9.0m | us-gaap:ResearchAndDevelopmentExpense |
| Research and development | 9 months2020-02-01 to 2020-10-31 | $26.9m | us-gaap:ResearchAndDevelopmentExpense |
| Operating income | 3 months2020-08-01 to 2020-10-31 | −$522.0k | us-gaap:OperatingIncomeLoss |
| Operating income | 9 months2020-02-01 to 2020-10-31 | −$2.2m | us-gaap:OperatingIncomeLoss |
| Net income | 3 months2020-08-01 to 2020-10-31 | −$413.0k | us-gaap:NetIncomeLoss |
| Net income | 9 months2020-02-01 to 2020-10-31 | −$1.8m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2020-08-01 to 2020-10-31 | −$0.02 | us-gaap:EarningsPerShareBasicAndDiluted |
| Diluted EPS | 9 months2020-02-01 to 2020-10-31 | −$0.08 | us-gaap:EarningsPerShareBasicAndDiluted |
| Operating cash flow | 9 months2020-02-01 to 2020-10-31 | $2.2m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 9 months2020-02-01 to 2020-10-31 | $2.3m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Cash and equivalents | At period end2020-10-31 | $15.5m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2020-10-31 | $53.4m | us-gaap:AssetsCurrent |
| Total assets | At period end2020-10-31 | $85.7m | us-gaap:Assets |
| Current liabilities | At period end2020-10-31 | $45.2m | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2020-10-31 | $48.3m | us-gaap:Liabilities |
| Shareholders' equity | At period end2020-10-31 | $37.5m | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001564590-20-056196. Last ingested by Listed: Oct 27, 2026, 16:11 ET. Listed shows no prices and gives no investment advice.